Mr. Overton Brings Over 15 Years of Experience Supporting Evolving Business Strategies with Leading IT Technologies to BioAgilytix in a Time of Rapid Growth and Scaling
BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, has announced the addition of Craig Overton to its leadership team as Director of IT & Facilities. In this role, Mr. Overton will oversee the strategic planning and implementation of leading IT technologies to support BioAgilytix’s business during a time of growth and scaling.
Mr. Overton, a Certified Lean Six Sigma Black Belt, brings with him over 15 years of experience successfully leveraging technology to drive, support, and deliver evolving business initiatives. During his most recent tenure as IT Infrastructure Manager at Xerox, he was responsible for redesigning and architecting the infrastructure, and introduced new strategies of continuous IT improvement aligned closely with the company’s technical and strategic objectives. “To be successful, technology decisions must be integrally aligned and evolved with strategic corporate initiatives, development objectives, and operational goals – while continuing to advance innovation and uphold integrity,” said Overton. “It’s exciting to join the BioAgilytix team in a phase where strategic systems harmonization and technology build-out will play an integral role in achieving the company’s vision for growth.”
Jim Datin, Chief Executive Officer of BioAgilytix, commented that “Craig’s background leading innovative planning and implementation of IT business strategies, plus his focus on lean architecture, make him a perfect fit for BioAgilytix at this time in our growth. He understands our business goals, as well as our customers’ stringent requirements for data integrity and protection, and will be instrumental in helping us efficiently – and securely – harmonize and scale our IT infrastructure as our laboratory sites continue to build a world class foundation.”
BioAgilytix is a leading bioanalytical testing laboratory specializing in large molecule bioanalysis. Located in North Carolina’s Research Triangle area, BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assay services supporting the development and release testing of biologics across a number of industries and disease states. BioAgilytix offers assay development, validation, and sample analysis under non-GLP, spirit-of-GLP, and GLP, as well as product release testing under GMP.
BioAgilytix’s team of highly experienced scientific and QA professionals ensures high quality science, sample and data integrity, and regulatory compliance through all phases of clinical development, and is a trusted partner to 19 of the top 30 global pharmaceutical and biotech companies. For more information, visit www.bioagilytix.com.